Reversal of multidrug resistance in human colon carcinoma cells

Details Reversal of multidrug resistance in human colon carcinoma cells Reversal of multidrug resistance in human colon carcinoma cells

2005-04-12

2005-04-12

Riley, Jezia (Department: 1637)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S411000, C514S415000, C514S279000, C514S280000

Reexamination Certificate

active

06878737

ABSTRACT:
The present invention describes the use of fumitremorgin A, B and C and a series of diketopiperazines of Formula (I) to resensitize multidrug resistant (MDR) cancer cells to the cytotoxic effects of chemotherapeutic drugs.

REFERENCES:
patent: 5387685 (1995-02-01), Powell et al.
Cole, R.J., and Cox, R.H., Tremorgen Group, in Handbook of Toxic Fungal Metabolites, 1981, Academic Press, New York, 355-367.
Durr, E E et al. Cancer Treat. Rev., 10, 3-11, 1983.
Bhalla, K. et al, Cancer Res., 45, 3657-3662, 1985.
D.M. Harrison et al., Tetrahedron Letters, vol. 27, No. 4, pp. 521-524, 1986.
M. Nakagawa et al., Tetrahedron Letters, vol. 27, No. 28, pp. 3235-3238, 1986.
Batist, G., et al, J.Biol. Chem., 261, 15544-15549, 1986.
R. Plante et al., J. Org. Chem. 1987, 52, 560-564.
Hindenburg, A.A., et al, Cancer Res., 47, 1421-1425, 1987.
Greenberger, L.M., et al, J.Biol.Chem., 262, 13685-13689, 1987.
Gruber, A. et al., Int. J. Cancer, 41, 224-226, 1988.
Kramer, R.A. et al, Science, 24(1), 694-697, 1988.
Dalton, W.S., et al, Cancer Res., 48, 1882-1888, 1988.
S. Kodato et al., Tetrahedron, vol. 44, No. 2, pp. 359-377, 1988.
Young, R.C. Drug resistance; the clinical problem, in Drug Resistance in Cancer Therapy, R.F. Ozols, Editor, Kluwer Acad. Press, Boston, 1-12, 1989.
M. Nakagawa et al., Chem. Pharm. Bull. 37(1), 23-32 (1989).
T. Hino et al., Tetrahedron, vol. 45, No. 7, pp. 1941-1944, 1989.
Goldstein, L.J. et al, J.Natl. Canc. Inst, 81, 116-124, 1989.
Lui, L.F., DNA topoisomerase posions as antitumor drugs, Annu. Rev. Biochem., 58, 351-375, 1989.
Nishiyama, M. and Kuga T., Japan J. Pharmacol., 50, 167-173, 1989.
Cole, S.P.C., et al, Br.J.Cancer, 59, 42-46, 1989.
Harker, W.C. et al, Cancer Res., 49, 4542-4549, 1989.
McGrath, T., et al, Cancer Res., 48, 3959-3963, 1989.
Ford, J.M. et al, Cancer Res., 50, 1748-1756, 1990.
Baas, R. et al, Cancer Res, 50, 5392-5398, 1990.
Ellason, J.F. et al, Int. J. Cancer, 46, 113-117, 1990.
Nishiyama, M. and Kuga T., Japan J. Pharmacol., 52, 201-208, 1990.
Chen, Y.N. et al, J. Biol. Chem., 265, 10073-10080, 1990.
Skehan, P. et al, J. Nat. Cancer Inst., 82, 1107-1112, 1990.
Dietel, M., et al. Cancer Res., 50, 6100-6106, 1990.
Rubinstein, L.V. et al, J. Nat. Cancer Inst., 82, 1113-1117, 1990.
Faulds, D., et al, Drugs, 41, 400-449, 1991.
Cowan, J.D. et al., J.Nat. Canc. Inst., 83, 1077-1084, 1991.
Taylor, C.W. et al, Br.J.Cancer, 63,923-929, 1991.
Harker, W.C. et al, Biochemistry, 30, 9953-9961, 1991.
Nakagawa, M., et al, Cancer Res., 52, 6175-6181, 1992.
Chabner, B.A., Campothecins, J.Clin.Oncol., 10, 3-4, 1992.
Versantvoort, C.H.M., et al, Br.J.Cancer, 68, 939-946, 1993.
Gottesman, M.M. and Pastan, I., Annu. Rev. Biochem, 62, 385-427, 1993.
Arceci, R.J., Blood, 81, 2215-2222, 1993.
Scheper, R.J. et al, Cancer Res., 53, 1475-1479, 1993.
Arceici, R.J. et al., Cancer Res., 53, 310-317, 1993.
Greenberger, L.M., et al., In Vitro Models of Multiple Drug Resistanc and L.J. Goldstein and R.F. Ozols, Editor Kluwer Academic Publishers, Norwell, MA, 69-106, 1994.
Sikic, B.I., et al, J. Clinical Reversal of Multidrug Resistance in Anticancer Drug Resistance, L.J. Goldstein and R.F. Ozols, Editor.
Kluwer Academic Publishers, Norwell, MA 149-165, 1994.
Zhang, X.P., et al, Oncol. Res., 6, 291-301, 1994.
Cole, S.P.C., et al. Cancer Res., 54, 5902-5910, 1994.
Zaman, C.J.R., et al, Proc. Natl. Acad. Sci. USA, 91, 8822-8826, 1994.
Jedlitschky, G. et al, Cancer Res., 54, 4833-4836, 1994.
Futscher, B.W. et al, Biochem. Pharmacol., 47, 1601-1606, 1994.
Flens, M.J. et al, Cancer Res., 54, 4557-4563, 1994.
Leier, I., et al, J. Biol.Chem, 269, 27807-27810, 1994.
Abe, T., et al, Br.J.Cancer, 72, 418-423, 1995.
Tasanki, Y., et al., J. Urology, 154, 1210-1216, 1995.
Gekeler, V., et al, Biochem. Biophs. Res. Commun., 206, 119-126, 1995.
Goldstein, L.J., Current Prob. Cancer, 19, 65-124, 1995.
Brock, I., et al, Cancer Res., 55, 459-462, 1995.
Harker, W.C. et al, Cancer Res., 55, 4962-4971, 1995.
Lois, A.F., et al, Cancer Res., 55, 4010-4013, 1995.
Yang, C.H. et al, Cancer Res., 55, 4004-4009, 1995.
Bow, E.J., J. Clin. Oncol., 14, 1345-1352, 1996.
Tannock, I.F., J. Clin. Oncol., 14, 1756-1764, 1996.
Loe, D.W., et al, European J. Cancer, 32A, 945-957, 1996.
Greenberger, L.M., et al, Oncol. Res., 8, 207-218, 1996.
C.B. Cui et al., Journal of Antibiotics, Jun. 1996.
T. Hino and M. Nakagawa, Heterocycles, vol. 46, 1997.
H. Wang and A. Ganesan, Tetrahedron Letters, vol. 38, No. 24, pp. 4327-4328, 1997.
O'Malley, Gerard J. et al, Tetrahedron Lett. (1987), 28(11), 1131-4.
Bailey, Patrick D., et al, Tetrahedron Lett., (1989), 30(46), 6421-2.
Bailey, Patrick D. et al, J.Chem.Soc., Perkin Trans. 1 (1993), (4), 451-8.
Cui, Cheng-Bin. et al, J. Antibiot. (1996), 49(6), 527-533.
Cui, Cheng-Bin, et al, Tetrahedron (1996), 52(39), 12651-12666.
Cui, Cheng-Bin, et al, Tennen Yuki Kagobutsu Toronkai Koen Yoshishu (1996), 38th, 49-54.
Cui, Cheng-Bin, et al, Tennen Yuki Kagobutsu Toronkai Koen Yoshishu (1996), 38th, 49-54. (English Abstract).
Rabindran, Sridhar K.; Cancer Res. Alert; 2, (2), 19-21, Jul. (2000).

Affiliated with

Also associated with

Rating

Reversal of multidrug resistance in human colon carcinoma cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reversal of multidrug resistance in human colon carcinoma cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reversal of multidrug resistance in human colon carcinoma cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3405225